Meeting
2023 ASCO Annual Meeting
The impact of social determinants of health (SDOH) on use of germline genetic testing for triple-negative breast cancer (TNBC) in the community oncology setting.
Authors
Robert Lawrence Reid
US Oncology Network/Virginia Cancer Specialists, Herndon, VA
Robert Lawrence Reid , Joseph Dye , Traci Leong , Barbara Kunz , Michael A. Danso , Janet L. Espirito , Karen L. Tedesco , Ranjit Goudar , Tifany Lewis , Becky Clark , Rachael Adger , Leanne Kocemba , Molly Mendenhall , Nicholas J. Robert
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Metastatic
Track
Breast Cancer
Sub Track
Triple-Negative
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 1094)
DOI
10.1200/JCO.2023.41.16_suppl.1094
Abstract #
1094
Poster Bd #
315
Abstract Disclosures
Similar Posters
Poster
2020 Gastrointestinal Cancers Symposium
Improving cascade genetic testing for families with inherited pancreatic cancer (PDAC) risk: The GENetic Education, Risk Assessment and TEsting (GENERATE) study.
First Author: Matthew B. Yurgelun
Poster
2019 ASCO Annual Meeting
Improving cascade genetic testing for families with inherited pancreatic cancer (PDAC) risk: The genetic education, risk assessment and testing (GENERATE) study.
First Author: Matthew B. Yurgelun
Poster
2023 ASCO Annual Meeting
Integrated clinical, pathologic, and genetic data in a racially diverse hereditary breast cancer cohort.
First Author: Kenna Noel Koehler
Poster
2023 ASCO Annual Meeting
A population-based study of BRCA breast cancer incidence and prognosis in the Italian Emilia Romagna region: The MUTina study.
First Author: Laura Cortesi